VMI

VHCP Management II Portfolio holdings

AUM $379M
1-Year Est. Return 424.39%
This Quarter Est. Return
1 Year Est. Return
+424.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$379M
AUM Growth
+$117M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1
+$36.5M
2
+$8.62M
3
+$5.29M
4
RLMD icon
Relmada Therapeutics
RLMD
+$4.48M
5
ADVM icon
Adverum Biotechnologies
ADVM
+$4.42M

Top Sells

1
+$22.6M
2
+$16M
3
+$15.7M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$13.6M
5
AXSM icon
Axsome Therapeutics
AXSM
+$11.1M

Sector Composition

1 Healthcare 99.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
1
10x Genomics
TXG
$1.54B
$136M 35.91%
1,786,431
AXSM icon
2
Axsome Therapeutics
AXSM
$6.24B
$81.2M 21.42%
785,981
-106,965
CNST
3
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$70.7M 18.64%
1,500,631
+773,954
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$25.2M 6.64%
462,903
-250,000
SWAV
5
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$12.7M 3.34%
288,838
-357,589
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.62M 2.27%
+1,004,299
KALV icon
7
KalVista Pharmaceuticals
KALV
$558M
$6.52M 1.72%
366,268
-10,621
OBSV
8
DELISTED
ObsEva SA Ordinary Shares
OBSV
$6.01M 1.58%
1,573,639
-678,821
MRSN icon
9
Mersana Therapeutics
MRSN
$52.6M
$5.29M 1.39%
+36,901
SPRO icon
10
Spero Therapeutics
SPRO
$132M
$4.56M 1.2%
474,015
RLMD icon
11
Relmada Therapeutics
RLMD
$66.7M
$4.48M 1.18%
+114,876
ADVM icon
12
Adverum Biotechnologies
ADVM
$95.7M
$4.42M 1.16%
+38,362
MRNS
13
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.21M 0.85%
371,669
FTSV
14
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$3.06M 0.81%
+77,714
MIST icon
15
Milestone Pharmaceuticals
MIST
$167M
$2.38M 0.63%
148,560
NXTC icon
16
NextCure
NXTC
$23.3M
$2.04M 0.54%
+3,021
MYOV
17
DELISTED
Myovant Sciences Ltd.
MYOV
$1.19M 0.31%
+76,768
ETNB icon
18
89bio
ETNB
$2.19B
$1.08M 0.29%
+41,235
BLPH
19
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$230K 0.06%
43,939
-232,686
PTGX icon
20
Protagonist Therapeutics
PTGX
$4.71B
$227K 0.06%
32,211
-394,570
RARX
21
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-677,164
LJPC
22
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-518,102
ASND icon
23
Ascendis Pharma
ASND
$12.5B
– –
-234,591
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.41B
– –
-2,874,602
KNSA icon
25
Kiniksa Pharmaceuticals
KNSA
$2.88B
– –
-540,461
1
2